Foals of mares vaccinated for Hendra virus have a suboptimal response to HeV vaccination

• Published in: Veterinary microbiology 2024-08, Vol.295, p.110167, Article 110167
• Main Authors: Carey, Kimberley J., Smith, Ina, Barr, Jennifer, Caruso, Sarah, Au, Gough G., Hartley, Carol A., Bailey, Kirsten E., Perriam, Wendy, Broder, Christopher C., Gilkerson, James R.
• Format: Article
• Language: English
• Subjects: Equine immunology; Foals; Hendra virus; Maternal antibodies; Vaccination
• ISSN: 0378-1135; 1873-2542; 1873-2542
• DOI: 10.1016/j.vetmic.2024.110167

Hendra virus (HeV) is lethal to horses and a zoonotic threat to humans in Australia, causing severe neurological and/or respiratory disease with high mortality. An equine vaccine has been available since 2012. Foals acquire antibodies from their dams by ingesting colostrum after parturition, therefore it is assumed that foals of mares vaccinated against HeV will have passive HeV antibodies circulating during the first several months of life until they are actively vaccinated. However, no studies have yet examined passive or active immunity against HeV in foals. Here, we investigated anti-HeV antibody levels in vaccinated mares and their foals. Testing for HeV neutralising antibodies is cumbersome due to the requirement for Biosafety level 4 (BSL-4) containment to conduct virus neutralisation tests (VNT). For this study, a subset of samples was tested for HeV G-specific antibodies by both an authentic VNT with infectious HeV and a microsphere-based immunoassay (MIA), revealing a strong correlation. An indicative neutralising level was then applied to the results of a larger sample set tested using the MIA. Mares had high levels of HeV-specific neutralising antibodies at the time of parturition. Foals acquired high levels of maternal antibodies which then waned to below predictive protective levels in most foals by 6 months old when vaccination commenced. Foals showed a suboptimal response to vaccination, suggesting maternal antibodies may interfere with active vaccination. The correlation analysis between the authentic HeV VNT and HeV MIA will enable further high throughput serological studies to inform optimal vaccination protocols for both broodmares and foals. •Luminex® microsphere immunoassay can indicate neutralising Hendra Virus antibodies.•Foals of mares vaccinated for Hendra Virus acquire protective passive antibodies.•Passive antibodies in foals waned to below protective levels by 3–6 months of age.•Foals from vaccinated mares had a suboptimal response to Hendra Virus vaccination.